Since 2020, Stefano Corvasce is Integrated Strategy Lead (iSL) Neuroscience at Roche Italy and directly responsible for commercial, access and medical strategy for neuroimmunological diseases. In the pharma industry since 2006, he acquired medical and marketing expertise, with increasing responsibilities. Pre-pharma experiences include academic research (PhD in Acquired Immune Deficiency Syndrome and Related Infections, University of Milan) and biostatistics / biometrics competencies (master in Biostatistics, University of Milan)